Brief: Ryvu Therapeutics Signs Financing Deal For Up To EUR 22 Mln With EIB
Aug 17 (Reuters) - Ryvu Therapeutics SA RVU.WA :
* SIGNS FINANCING AGREEMENT WITH THE EUROPEAN INVESTMENT
BANK
(EIB) FOR UP TO EUR 22.0 MILLION
* AGREEMENT TO SUPPORT DEVELOPMENT OF RVU120 MOLECULE
* AGREEMENT ALSO TO SUPPORT OTHER COMPANYS PROJECTS IN
EARLIER
STAGE OF DEVELOPMENT
Source text for Eikon: ID:nEM9J4d8Da
Further company coverage: RVU.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Signs Grant Agreement For Panacea-Novo Project With The National Center For Research And Development
Brief: Ryvu Therapeutics Q2 Net Loss 13.1 Million Zlotys
Brief: Ryvu Therapeutics "Dualis" Project Recommended For 22.2 Mln Zloty Subsidy
Brief: Ryvu Therapeutics Launches Early Clinical Development Services Business For Biotech And Pharma In Europe
Brief: Ryvu Therapeutics Says Panacea-Novo Project Recommended For Funding Of 106.7 Mln Zlotys